Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-014803
Filing Date
2023-04-26
Accepted
2023-04-26 16:10:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A rphm_2023_proxy_material.htm DEFA14A 21060
2 GRAPHIC img230470812_0.jpg GRAPHIC 1079936
3 GRAPHIC img230470812_1.jpg GRAPHIC 427885
  Complete submission text file 0000950170-23-014803.txt   2094850
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40315 | Film No.: 23849820
SIC: 2834 Pharmaceutical Preparations